Ortel T KF, Kane W. Factor V. New York: M. Dekker; 1995.
Williamson MA, Snyder LM, Wallach JB. Wallach's interpretation of diagnostic tests. 9th ed. Wolters Kluwer/Lippincott Williams & Wilkins Health: Philadelphia; 2011.
Pagana KD, Pagana TJ, Pagana TN. Mosby’s Diagnostic & Laboratory Test Reference. 14th ed. St. Louis, Mo: Elsevier; 2019.
Tinholt M, Stavik B, Tekpli X, et al. Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer. Oncoimmunology. 2020 Sep 29. 9 (1):1824644. [Medline]. [Full Text].
Duckers C, Simioni P, Rosing J, Castoldi E. Advances in understanding the bleeding diathesis in factor V deficiency. Br J Haematol. 2009 Jun. 146(1):17-26. [Medline].
Owren PA. Parahaemophilia; haemorrhagic diathesis due to absence of a previously unknown clotting factor. Lancet. 1947 Apr 5. 1(6449):446-8. [Medline].
Gould WR, Simioni P, Silveira JR, Tormene D, Kalafatis M, Tracy PB. Megakaryocytes endocytose and subsequently modify human factor V in vivo to form the entire pool of a unique platelet-derived cofactor. J Thromb Haemost. 2005 Mar. 3(3):450-6. [Medline].
Gould WR, Silveira JR, Tracy PB. Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor: characterization of purified platelet-derived factor V/Va. J Biol Chem. 2004 Jan 23. 279(4):2383-93. [Medline].
Oliver JA, Monroe DM, Church FC, Roberts HR, Hoffman M. Activated protein C cleaves factor Va more efficiently on endothelium than on platelet surfaces. Blood. 2002 Jul 15. 100(2):539-46. [Medline].
Sun H, Yang TL, Yang A, Wang X, Ginsburg D. The murine platelet and plasma factor V pools are biosynthetically distinct and sufficient for minimal hemostasis. Blood. 2003 Oct 15. 102(8):2856-61. [Medline].
Monkovic DD, Tracy PB. Activation of human factor V by factor Xa and thrombin. Biochemistry. 1990 Feb 6. 29(5):1118-28. [Medline].
Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994 May 5. 369(6475):64-7. [Medline].
Cui J, O'Shea KS, Purkayastha A, Saunders TL, Ginsburg D. Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V. Nature. 1996 Nov 7. 384(6604):66-8. [Medline].
Shen L, Dahlback B. Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa. J Biol Chem. 1994 Jul 22. 269(29):18735-8. [Medline].
JH G. Control of Coagulation Reaction. Prchal JT KK, Lichtman MA, Kipps TJ, Seligsohn U,, ed. Williams Hematology. New York: McGraw-Hill; 2010.
Smyth SS WS, Italiano JE, Coller BS. Platelet Morphology, Biochemistry, and Function. Prchal JT KK, Lichtman MA, Kipps TJ, Seligsohn U, ed. Williams Hematology. 8th ed. New York: McGraw-Hill; 2010.
Bouchard BA BS, Mann KG, et al. Interactions between platelets and the coagulation system. Michelson AD, ed. Platelets. San Diego. London: Academic Press; 2002. 956.
Ellery PER, Hilden I, Thyregod P, et al. Measurement of plasma and platelet tissue factor pathway inhibitor, factor V and Protein S in people with haemophilia. Haemophilia. 2019 Nov. 25 (6):1083-91. [Medline].
Link KG, Stobb MT, Sorrells MG, et al. A mathematical model of coagulation under flow identifies factor V as a modifier of thrombin generation in hemophilia A. J Thromb Haemost. 2020 Feb. 18 (2):306-17. [Medline].
Sridharan M, Fylling KA, Ashrani AA, et al. Clinical and laboratory diagnosis of autoimmune factor V inhibitors: a single institutional experience. Thromb Res. 2018 Nov. 171:14-21. [Medline].
Hamedani AG, Cole JW, Cheng Y, Sparks MJ, O'Connell JR, Stine OC. Factor V Leiden and Ischemic Stroke Risk: The Genetics of Early Onset Stroke (GEOS) Study. J Stroke Cerebrovasc Dis. 2011 Nov 17. [Medline].
